Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-Canp

Key Points

• This research aims to evaluate the efficacy and safety of mirogabalin combined with opioids compared to opioids alone in treating neuropathic cancer pain.
• Conducted as a clinical trial in Japan
• Compared two treatment groups: mirogabalin + opioids vs. opioids alone
• Measured efficacy and safety outcomes in neuropathic cancer pain patients
• Mirogabalin combined with opioids showed improved pain relief compared to opioids alone
• Safety profiles were similar in both treatment groups
• Data indicate a significant reduction in neuropathic pain using the combination therapy